Literature DB >> 16645125

Oligomerization of recombinant and endogenously expressed human histamine H(4) receptors.

Richard M van Rijn1, Paul L Chazot, Fiona C Shenton, Kamonchanok Sansuk, Remko A Bakker, Rob Leurs.   

Abstract

In this study, we report the homo- and hetero-oligomerization of the human histamine H(4)R by both biochemical (Western blot and immobilized metal affinity chromatography) and biophysical [bioluminescence resonance energy transfer and time-resolved fluorescence resonance energy transfer (tr-FRET)] techniques. The H(4)R receptor is the most recently discovered member of the histamine family of G-protein-coupled receptors. Using specific polyclonal antibodies raised against the C-terminal tail of the H(4)R, we demonstrate the presence of H(4)R oligomers in human embryonic kidney 293 and COS-7 cells heterologously overexpressing H(4)Rs and putative native H(4)R oligomers in human phytohaemagglutinin blasts endogenously expressing H(4)Rs. Moreover, we show that H(4)R homo-oligomers are formed constitutively, are formed at low receptor densities (300 fmol/mg of protein), and are present at the cell surface, as detected by tr-FRET. The formation of these oligomers is independent of N-glycosylation and is not modulated by H(4)R ligands, covering the full spectrum of agonists, neutral antagonists, and inverse agonists. Although we show H(4)R homo-oligomer formation at physiological expression levels, the detection of H(1)R-H(4)R hetero-oligomers was achieved only at higher H(1)R expression levels and are most likely not physiologically relevant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645125     DOI: 10.1124/mol.105.020818

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Commercially available antibodies against human and murine histamine H₄-receptor lack specificity.

Authors:  Silke Beermann; Roland Seifert; Detlef Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-10       Impact factor: 3.000

2.  Well characterized antihistamine 4 receptor antibodies contribute to current knowledge of the expression and biology of the human and murine histamine 4 receptor.

Authors:  Ralf Gutzmer; Thomas Werfel; Wolfgang Bäumer; Manfred Kietzmann; Paul L Chazot; Rob Leurs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-14       Impact factor: 3.000

3.  Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.

Authors:  Ana Jorge-Finnigan; Rune Kleppe; Kunwar Jung-Kc; Ming Ying; Michael Marie; Ivan Rios-Mondragon; Michael F Salvatore; Jaakko Saraste; Aurora Martinez
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

Review 4.  Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.

Authors:  C Hawkes; A Amritraj; R G Macdonald; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

5.  The four major N- and C-terminal splice variants of the excitatory amino acid transporter GLT-1 form cell surface homomeric and heteromeric assemblies.

Authors:  Eleanor Peacey; Christopher C J Miller; John Dunlop; Marcus Rattray
Journal:  Mol Pharmacol       Date:  2009-02-06       Impact factor: 4.436

Review 6.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

7.  Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer.

Authors:  Woo Hyun Paik; Ji Kon Ryu; Kyoung-Sin Jeong; Jin Myung Park; Byeong Jun Song; Sang Hyub Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

8.  Expression and function of histamine H4 receptor in mouse splenic dendritic cells.

Authors:  T Simon; I Jelinek; Gy Apponyi; V László; E Rajnavölgyi; A Falus
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

9.  Specific oligomerization of the 5-HT1A receptor in the plasma membrane.

Authors:  Andrew Woehler; Jakub Wlodarczyk; Evgeni G Ponimaskin
Journal:  Glycoconj J       Date:  2008-10-14       Impact factor: 2.916

10.  HTRF: A technology tailored for drug discovery - a review of theoretical aspects and recent applications.

Authors:  François Degorce; Amy Card; Sharon Soh; Eric Trinquet; Glenn P Knapik; Bing Xie
Journal:  Curr Chem Genomics       Date:  2009-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.